Results 101 to 110 of about 24,842 (206)

Lymphocytic Choriomeningitis Virus Infections among American Indians

Emerging Infectious Diseases, 2013
Barbara Knust, Robert C. Holman, John Redd, Jason M. Mehal, Steven M. Grube, Adam MacNeil, James Cheek, Pierre E. Rollin   +7 more
doaj   +1 more source

Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis

Viruses
Immunotherapy with checkpoint inhibitors, albeit commonly used against tumors, is still at its infancy against chronic virus infections. It relies on the reinvigoration of exhausted T lymphocytes to eliminate virus-infected cells. Since T cell exhaustion
Valentina Casella, Paula Cebollada Rica, Jordi Argilaguet, Enric Vidal, María González-Cao, Roberto Güerri-Fernandez, Gennady Bocharov, Andreas Meyerhans   +7 more
doaj   +1 more source

Characterization of VSV-GP morphology by cryo-EM imaging and SEC-MALS

Molecular Therapy: Methods & Clinical Development
Vesicular stomatitis virus expressing the glycoprotein of the lymphocytic choriomeningitis virus (VSV-GP) is a promising platform for oncolytic viruses and cancer vaccines.
Dongyue Xin, Leela Kurien, Katherine Briggs, Adrian Schimek, Richard Dambra, Daniel Hochdorfer, Tanja A. Arnouk, Marija Brgles, Saurabh Gautam, Dominik Hotter, Johannes Solzin, Thomas Kriehuber, Joseph Ashour, Adam Vigil, Michael Hawley, Xiaorong He   +15 more
doaj   +1 more source

PDIA4 Is a Host Factor Important for Lymphocytic Choriomeningitis Virus Infection. [PDF]

Viruses, 2023
Xu M, Xu H, Wan W, Jian X, Jin R, Wang L, Wang J, Xiao G, Zhang L, Chen H, Wen Y.   +10 more
europepmc   +1 more source

Rolle viraler Infektionen in der Transplantationsmedizin [PDF]

, 2017
Graft versus host disease (GvHD) tritt in 40% der Fälle bei Patienten nach MHC I abgeglichener Knochenmarktransplantation (KMT) auf. Mechanismen, die diese Krankheit verursachen, sind noch zu untersuchen.
Gassa, Asmae
core  

Human cases of lymphocytic choriomeningitis virus (LCMV) infections in Hungary. [PDF]

Arch Virol, 2023
Pankovics P, Nagy A, Nyul Z, Juhász A, Takáts K, Boros Á, Reuter G.   +6 more
europepmc   +1 more source

Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes [PDF]

, 1990
Although the relative contribution of different immune effector functions to clearing tissues of cytomegalovirus is controversial, the contribution of CD8+ T lymphocytes has generally been accepted as essential. In this report, we show that under certain
Jonjic, Stipan, Koszinowski, Ulrich H., Lucin, Pero, Pavic, Ivica, Rukavina, Daniel   +4 more
core  

Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors. [PDF]

, 2019
The tremendous clinical success of immune checkpoint inhibition (ICI), particularly targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand 1/2 (PD-L1/2) pathway, has resulted in application to multiple cancers, as a monotherapy and ...
Le, Catherine T, Murphy, William J
core   +1 more source

Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus. [PDF]

Cell Chem Biol, 2023
Moon-Walker A, Zhang Z, Zyla DS, Buck TK, Li H, Diaz Avalos R, Schendel SL, Hastie KM, Crotty S, Saphire EO.   +9 more
europepmc   +1 more source

External quality assessment of orthohantavirus and lymphocytic choriomeningitis virus molecular detection and serology in Europe, 2021. [PDF]

Euro Surveill, 2023
Erdin M, Stanoeva KR, Mögling R, Korva M, Knap N, Resman Rus K, Domingo C, Reimerink JH, de Vries A, Alburkat H, Utriainen M, Gossner CM, Sironen T, Avšič-Županc T, Reusken CB, Vapalahti O.   +15 more
europepmc   +1 more source